Author/Authors :
Berwanger، نويسنده , , Bernd and Hartmann، نويسنده , , Oliver and Bergmann، نويسنده , , Eckhard and Bernard، نويسنده , , Sandra and Nielsen، نويسنده , , Dirk and Krause، نويسنده , , Michael and Kartal، نويسنده , , Ali and Flynn، نويسنده , , Daniel and Wiedemeyer، نويسنده , , Ruprecht and Schwab، نويسنده , , Manfred and Schنfer، نويسنده , , Helmut and Christiansen، نويسنده , , Holger and Eilers، نويسنده , , Martin، نويسنده ,
Abstract :
Tumor stage, age of patient, and amplification of MYCN predict disease outcome in neuroblastoma. To gain insight into the underlying molecular pathways, we have obtained expression profiles from 94 primary neuroblastoma specimens. Advanced tumor stages show a characteristic expression profile that includes downregulation of multiple genes involved in signal transduction through Fyn and the actin cytoskeleton. High expression of Fyn and high Fyn kinase activity are restricted to low-stage tumors. In culture, expression of active Fyn kinase induces differentiation and growth arrest of neuroblastoma cells. Expression of Fyn predicts long-term survival independently of MYCN amplification. Amplification of MYCN correlates with deregulation of a distinct set of genes, many of which are target genes of Myc. Our data demonstrate a causal role for Fyn kinase in the genesis of neuroblastoma.
